/

OMCL

Omnicell, Inc.Pre-market

36.87+1.05 +2.93%USD

NasdaqGS · as of Oct 12, 16:00 ET · 15m delay

Open

35.87

Prev close

35.82

Day range

35.5937.17

52-week range

29.0655.00

Volume

459.03K0.69×

Mkt cap

1.68B

P/E ttm

43.89

Fwd P/E

17.64

EPS ttm

0.8400

Div yield

0.00%

Earnings

Oct 29, 2026

From 52w high

−32.96%

Price Chart

Yahoo Finance · delayed

OMCLOct 12, 2026O 35.87H 37.17L 35.59C 36.87+1.05 (+2.93%)Vol 459.00K

SMA 5034.71
SMA 20039.84

1Y change +24.06% since Oct 10, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

OMCL Omnicell, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +6.44%
1 month: +12.44%
3 months: −21.02%
6 months: +5.31%
Year to date: −18.61%
1 year: +24.06%

Valuation & ownership

Market cap: 1.68B
Enterprise value: 1.59B
P/E (ttm): 43.89
Forward P/E: 17.64
PEG ratio: 15.40
Price / book: 1.30
Price / sales (ttm): 1.34
EV / EBITDA: 19.34
EPS (ttm): 0.8400
EPS (forward): 2.09
Beta (5y monthly): 0.99
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 45.48M
Float: 44.38M
Short % of float: 9.68%
Short ratio (days): 6.14
Held by insiders: 2.15%
Held by institutions: 108.39%
Avg volume (3m): 668.67K
50-day average: 34.71
200-day average: 39.84
52-week change: +24.06%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 65.3
vs 50-day SMA: +6.23%
vs 200-day SMA: −7.45%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 3.07%
Realised vol (20d, ann.): 26.5%
From 52-week high: −32.96%
From 52-week low: +26.88%

ANR

Analyst Consensus

7 analysts

Consensus

—

Mean target

57.86

+56.92% implied

Low 45.00Median 60.00High 70.00

Recommendation trend

Now7 / 1 / 0
1m ago7 / 1 / 0

DES

About Omnicell, Inc.

Yahoo Finance profile

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Sector: Healthcare
Industry: Health Information Services
Employees: 3,485
Headquarters: Fort Worth, TX, United States
Website: omnicell.com
Officers

SEAS

Seasonality · OMCL

2007–2026 · monthly returns

Strongest month Jul +3.90%Weakest month Jan −2.88%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	7.1	-15.3	-18.8	24.1	6.6	-5.9	-14.8	-0.6	-3.2	8.3			−18.6%
2025	1.1	-15.4	-8.1	-10.6	-2.8	-3.2	5.5	5.1	-6.6	10.2	8.8	24.1	+1.8%
2024	-14.5	-18.4	11.4	-8.3	21.6	-16.9	7.9	52.3	-2.0	11.6	-4.2	-4.4	+18.3%
2023	10.0	-1.9	7.8	3.6	20.8	0.3	-14.3	-10.0	-20.8	-21.1	-6.1	12.8	−25.4%
2022	-16.8	-13.9	0.2	-15.7	1.8	2.3	-3.2	-7.1	-14.9	-11.2	-33.3	-2.3	−72.1%
2021	-1.8	7.7	2.3	11.7	-4.2	9.0	-3.3	6.0	-4.4	20.0	-0.6	1.9	+50.3%
2020	-0.5	0.2	-19.5	11.2	-8.2	5.5	-0.5	-5.1	12.0	15.9	21.1	14.5	+46.9%
2019	6.4	30.4	-4.8	-0.6	-1.1	8.3	-12.6	-4.5	0.7	-2.6	13.6	2.2	+33.4%
2018	1.1	-11.0	-0.6	-0.7	8.0	12.7	13.4	15.5	4.6	-1.7	9.2	-20.7	+26.3%
2017	5.9	5.9	6.9	1.8	-3.6	8.0	15.1	3.4	-0.5	-2.4	5.2	-7.4	+43.1%
2016	-9.9	-2.2	1.8	14.3	1.5	5.8	13.0	-2.8	1.9	-14.8	9.9	-5.4	+9.1%
2015	-3.9	10.1	0.1	1.2	4.1	2.0	-3.2	-7.0	-8.5	-12.5	10.9	3.1	−6.2%
2014	1.1	11.5	-0.6	-7.5	0.2	8.2	-4.6	2.7	-2.9	18.2	-0.3	2.9	+29.7%
2013	6.3	13.9	4.9	-4.6	0.6	13.3	2.7	3.0	8.9	-2.6	5.1	5.3	+71.7%
2012	-6.3	-3.6	1.9	-6.2	-8.3	11.8	-10.9	10.0	-3.2	4.9	4.7	-2.6	−10.0%
2011	-3.7	-3.4	13.4	0.9	0.2	1.2	9.7	-8.6	-11.9	8.5	8.1	2.2	+14.3%
2010	2.5	12.9	3.7	-4.8	-1.9	-10.8	5.4	-9.4	17.2	6.8	-4.1	7.8	+23.6%
2009	-36.0	-8.1	8.9	12.5	4.4	17.0	15.5	-11.6	1.5	-11.7	3.7	14.6	−4.3%
2008	-6.9	-24.2	5.8	-40.2	10.5	-0.8	23.3	-5.5	-14.3	-16.5	3.3	7.7	−54.7%
2007	11.3	-6.4	7.8	9.7	-1.9	-7.7	14.9	1.1	18.2	-7.5	-0.1	2.1	+44.6%

INSD

Insider Activity · OMCL

Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

50.7K shares

Sells, 6 months

21.2K shares

Net shares

+29.5K

Net change in insider shares

+3.10%

Date	Insider	Transaction	Shares	Value
Aug 16, 2026	Njoku NnamdiPresident	Sale at price 36.85 per share.	3.1K	$113.61K
Jul 14, 2026	Lipps Randall AChief Executive Officer	Sale at price 47.00 per share.	10K	$470.00K
Jun 30, 2026	Njoku NnamdiPresident	Stock Award(Grant) at price 0.00 per share.	12.3K	—
May 31, 2026	Seim Robin GeneDirector	Stock Award(Grant) at price 0.00 per share.	4.8K	—
May 31, 2026	Parrish Mark WayneDirector	Stock Award(Grant) at price 0.00 per share.	4.8K	—
May 31, 2026	Garrett MaryDirector	Stock Award(Grant) at price 0.00 per share.	5K	—
May 31, 2026	Voynick Eileen J.Director	Stock Award(Grant) at price 0.00 per share.	4.8K	—
May 31, 2026	Scott Bruce EDirector	Stock Award(Grant) at price 0.00 per share.	4.6K	—
May 31, 2026	Ghoshal KaushikDirector	Stock Award(Grant) at price 0.00 per share.	4.6K	—
May 31, 2026	Bauer Joanne BDirector	Stock Award(Grant) at price 0.00 per share.	5K	—
May 31, 2026	Bousa Edward PeterDirector	Stock Award(Grant) at price 0.00 per share.	4.6K	—
May 17, 2026	Manley Corey JOfficer	Sale at price 43.22 per share.	5K	$217.18K
May 17, 2026	Njoku NnamdiChief Operating Officer	Sale at price 43.22 per share.	3.1K	$133.55K
Mar 31, 2026	Lipps Randall AChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	90.9K	—
Mar 31, 2026	Manley Corey JOfficer	Stock Award(Grant) at price 0.00 per share.	25.1K	—
Mar 31, 2026	Njoku NnamdiChief Operating Officer	Stock Award(Grant) at price 0.00 per share.	46.3K	—
Mar 31, 2026	Radford Harlan Baird IiiChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	37K	—
Mar 31, 2026	Nutt Brian HOfficer	Stock Award(Grant) at price 0.00 per share.	5.6K	—
Mar 15, 2026	Manley Corey JOfficer	Sale at price 34.69 per share.	7.4K	$256.88K
Mar 12, 2026	Manley Corey JOfficer	Stock Award(Grant) at price 0.00 per share.	22.4K	—

OMCL

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

OMCL

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Omnicell, Inc.

Seasonality · OMCL

Insider Activity · OMCL

Congress Trades · OMCL

Congress Trades · OMCL

Insider Activity · OMCL

Seasonality · OMCL

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Omnicell, Inc.

Financial Snapshot

Earnings & Dividends

News